First human test of new lupus drug begins
NCT ID NCT06955598
Summary
This early-stage study tested a new injectable drug called SHR-2173 in 30 adults with lupus. The main goal was to check if the drug is safe and how the body processes it. Researchers gave multiple injections under the skin to understand side effects and how the drug behaves in people with this autoimmune condition.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SYSTEMIC LUPUS ERYTHEMATOSUS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Renji Hospital affiliated to Shanghai Jiaotong
Shanghai, Shanghai Municipality, 200000, China
Conditions
Explore the condition pages connected to this study.